Cargando…

Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects

Sirolimus (SRL) and everolimus (EVR) are mammalian targets of rapamycin inhibitors (mTOR-I) largely employed in renal transplantation and oncology as immunosuppressive/antiproliferative agents. SRL was the first mTOR-I produced by the bacterium Streptomyces hygroscopicus and approved for several med...

Descripción completa

Detalles Bibliográficos
Autores principales:	Granata, Simona, Dalla Gassa, Alessandra, Carraro, Amedeo, Brunelli, Matteo, Stallone, Giovanni, Lupo, Antonio, Zaza, Gianluigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881557/ https://www.ncbi.nlm.nih.gov/pubmed/27187382 http://dx.doi.org/10.3390/ijms17050735

Ejemplares similares

Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen
por: Zaza, Gianluigi, et al.
Publicado: (2017)

Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease
por: Granata, Simona, et al.
Publicado: (2016)

Mitochondria: a new therapeutic target in chronic kidney disease
por: Granata, Simona, et al.
Publicado: (2015)

Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in “Omics” Medicine
por: Zaza, Gianluigi, et al.
Publicado: (2015)

Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase
por: Masola, Valentina, et al.
Publicado: (2013)

Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro
por: Masola, Valentina, et al.
Publicado: (2015)

mRNA as a medicine in nephrology: the future is now
por: Granata, Simona, et al.
Publicado: (2023)

mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis
por: Granata, Simona, et al.
Publicado: (2021)

Skin cancer in solid organ transplant recipients: still an open problem
por: Granata, Simona, et al.
Publicado: (2023)

Inflammasome pathway in kidney transplantation
por: Granata, Simona, et al.
Publicado: (2023)

Cellular Effects of Everolimus and Sirolimus on Podocytes
por: Müller-Krebs, Sandra, et al.
Publicado: (2013)

In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets
por: Granata, Simona, et al.
Publicado: (2018)

In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells
por: Masola, Valentina, et al.
Publicado: (2019)

mTOR-inhibitors and post-transplant diabetes mellitus: a link still debated in kidney transplantation
por: Granata, Simona, et al.
Publicado: (2023)

Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease
por: Signorini, Lorenzo, et al.
Publicado: (2017)

Autophagy Activation in Peripheral Blood Mononuclear Cells of Peritoneal Dialysis Patients
por: Granata, Simona, et al.
Publicado: (2023)

How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center
por: Zaza, Gianluigi, et al.
Publicado: (2015)

A Comprehensive Proteomics Analysis of Urinary Extracellular Vesicles Identifies a Specific Kinase Protein Profile as a Novel Hallmark of Medullary Sponge Kidney Disease
por: Bruschi, Maurizio, et al.
Publicado: (2022)

Proteomic analysis of urinary extracellular vesicles of kidney transplant recipients with BKV viruria and viremia: A pilot study
por: Bruschi, Maurizio, et al.
Publicado: (2022)

Monoclonal Antibody Therapy and Renal Transplantation: Focus on Adverse Effects
por: Zaza, Gianluigi, et al.
Publicado: (2014)

Sirolimus-induced interstitial lung disease and resolution after conversion to everolimus
por: Alkhunaizi, Ahmed M., et al.
Publicado: (2020)

Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature
por: Wagle Shukla, Aparna, et al.
Publicado: (2023)

Oxidative Stress and Ischemia/Reperfusion Injury in Kidney Transplantation: Focus on Ferroptosis, Mitophagy and New Antioxidants
por: Granata, Simona, et al.
Publicado: (2022)

Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors
por: Zaza, Gianluigi, et al.
Publicado: (2013)

Everolimus and Sirolimus in Combination with Cyclosporine Have Different Effects on Renal Metabolism in the Rat
por: Bohra, Rahul, et al.
Publicado: (2012)

Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study
por: Sahman, Majda, et al.
Publicado: (2021)

Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease
por: Zaza, Gianluigi, et al.
Publicado: (2023)

Everolimus- and sirolimus-eluting stents in patients with and without ST-segment elevation myocardial infarction
por: Velders, M. A., et al.
Publicado: (2014)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
por: Hawranek, Michał, et al.
Publicado: (2021)

Effects of a ritonavir‐containing regimen on the pharmacokinetics of sirolimus or everolimus in healthy adult subjects
por: Zha, Jiuhong, et al.
Publicado: (2022)

Proteomics reveals specific biological changes induced by the normothermic machine perfusion of donor kidneys with a significant up-regulation of Latexin
por: Zaza, Gianluigi, et al.
Publicado: (2023)

Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury
por: Masola, Valentina, et al.
Publicado: (2018)

Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients
por: Zaza, Gianluigi, et al.
Publicado: (2014)

Simultaneous Determination of Cyclosporine A, Tacrolimus, Sirolimus, and Everolimus in Whole-Blood Samples by LC-MS/MS
por: Karapirli, Mustafa, et al.
Publicado: (2012)

Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents
por: Velders, Matthijs A., et al.
Publicado: (2013)

Accuracy evaluation of automated electrochemiluminescence immunoassay for everolimus and sirolimus compared to liquid chromatography‐tandem mass spectrometry
por: Lee, Eun Jin, et al.
Publicado: (2019)

Effect of Sirolimus vs. Everolimus on CMV-Infections after Kidney Transplantation—A Network Meta-Analysis
por: Wolf, Sebastian, et al.
Publicado: (2022)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
por: Jafaripour, Iraj, et al.
Publicado: (2023)

Downregulation of Nuclear-Encoded Genes of Oxidative Metabolism in Dialyzed Chronic Kidney Disease Patients
por: Zaza, Gianluigi, et al.
Publicado: (2013)

A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients
por: Zaza, Gianluigi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qpucd3utpldcggpo9qovoe9nm1